"The Report
Pre-Eclampsia - Pipeline Review, H1 2016 provides information on
pricing, market analysis, shares, forecast, and company profiles for
key industry participants. - MarketResearchReports.biz"
Global
Markets Directs, Pre-Eclampsia
- Pipeline Review, H1 2016,
provides an overview of the Pre-Eclampsia pipeline landscape.
The
report provides comprehensive information on the therapeutics under
development for Pre-Eclampsia, complete with analysis by stage of
development, drug target, mechanism of action (MoA), route of
administration (RoA) and molecule type. The report also covers the
descriptive pharmacological action of the therapeutics, its complete
research and development history and latest news and press releases.
Additionally, the report provides an overview of key players involved
in therapeutic development for Pre-Eclampsia and features dormant and
discontinued projects.
Global
Markets Directs report features investigational drugs from across
globe covering over 20 therapy areas and nearly 3,000 indications.
The report is built using data and information sourced from Global
Markets Directs proprietary databases, company/university websites,
clinical trial registries, conferences, SEC filings, investor
presentations and featured press releases from company/university
sites and industry-specific third party sources. Drug profiles
featured in the report undergoes periodic review following a
stringent set of processes to ensure that all the profiles are
updated with the latest set of information. Additionally, various
dynamic tracking processes ensure that the most recent developments
are captured on a real time basis.
The
report helps in identifying and tracking emerging players in the
market and their portfolios, enhances decision making capabilities
and helps to create effective counter strategies to gain competitive
advantage.
Scope
-
The report provides a snapshot of the global therapeutic landscape of
Pre-Eclampsia
-
The report reviews pipeline therapeutics for Pre-Eclampsia by
companies and
universities/research
institutes based on information derived from company and
industry-specific sources
-
The report covers pipeline products based on various stages of
development ranging from pre-registration till discovery and
undisclosed stages
-
The report features descriptive drug profiles for the pipeline
products which includes, product description, descriptive MoA, R&D
brief, licensing and collaboration details & other developmental
activities
-
The report reviews key players involved Pre-Eclampsia therapeutics
and enlists all their major and minor projects
-
The report assesses Pre-Eclampsia therapeutics based on drug target,
mechanism of action (MoA), route of administration (RoA) and molecule
type
-
The report summarizes all the dormant and discontinued pipeline
projects
-
The report reviews latest news related to pipeline therapeutics for
Pre-Eclampsia
Reasons to buy
-
Gain strategically significant competitor information, analysis, and
insights to formulate effective R&D strategies
-
Identify emerging players with potentially strong product portfolio
and create effective counter-strategies to gain competitive advantage
-
Identify and understand important and diverse types of therapeutics
under development for Pre-Eclampsia
-
Identify potential new clients or partners in the target demographic
-
Develop strategic initiatives by understanding the focus areas of
leading companies
-
Plan mergers and acquisitions effectively by identifying key players
and its most promising pipeline therapeutics
-
Devise corrective measures for pipeline projects by understanding
Pre-Eclampsia pipeline depth and focus of Indication therapeutics
-
Develop and design in-licensing and out-licensing strategies by
identifying prospective partners with the most attractive projects to
enhance and expand business potential and scope
-
Modify the therapeutic portfolio by identifying discontinued projects
and understanding the factors that drove them from pipeline
Browse More PressRelease:
Table
of Contents
Table
of Contents 2
List
of Tables 4
List
of Figures 4
Introduction
5
Global
Markets Direct Report Coverage 5
Pre-Eclampsia
Overview 6
Therapeutics
Development 7
Pipeline
Products for Pre-Eclampsia - Overview 7
Pre-Eclampsia
- Therapeutics under Development by Companies 8
Pre-Eclampsia
- Pipeline Products Glance 9
Late
Stage Products 9
Clinical
Stage Products 10
Early
Stage Products 11
Pre-Eclampsia
- Products under Development by Companies 12
Pre-Eclampsia
- Companies Involved in Therapeutics Development 13
A1M
Pharma AB 13
Alnylam
Pharmaceuticals, Inc. 14
Glenveigh
Medical, LLC 15
Pluristem
Therapeutics Inc. 16
rEVO
Biologics, Inc. 17
RTI
International 18
VG
Life Sciences, Inc. 19
Pre-Eclampsia
- Therapeutics Assessment 20
Assessment
by Monotherapy Products 20
Assessment
by Target 21
Assessment
by Mechanism of Action 23
Assessment
by Route of Administration 25
Assessment
by Molecule Type 27
Drug
Profiles 29
A1M-001
- Drug Profile 29
Product
Description 29
Mechanism
of Action 29
R&D
Progress 29
ALN-AGT
- Drug Profile 31
About us
MarketResearchReports.biz
is the most comprehensive collection of market research reports.
MarketResearchReports.Biz services are specially designed to save
time and money for our clients. We are a one stop solution for all
your research needs, our main offerings are syndicated research
reports, custom research, subscription access and consulting
services. We serve all sizes and types of companies spanning across
various industries.
Contact
Mr.
Nachiket
State Tower
90
Sate Street, Suite 700
Albany,
NY 12207
Tel:
+1-518-621-2074
No comments:
Post a Comment